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Recent years have witnessed a quiet revolution in biology
as seemingly disparate fields, as far apart as biophysics
and medical specialties such as human genetics and car-
diovascular diseases, have begun to merge. Studies of
molecular chaperones have bridged the gaps between
biophysics and medical genetics, and they provide a clear
example of promise of the new synthetic approach. Bio-
physicists, using nuclear magnetic resonance spectros-
copy and other techniques in cell-free systems, have elu-
cidated some of the basic mechanisms of protein folding,
and they have shown that chaperone proteins participate
in multiple steps in the folding pathway of model sub-
strates (Dobson and Ellis 1998; Richardson et al. 1998).
Microbial geneticists and cell biologists have also found
that similar chaperones also act in off-pathway events
such as aggregation and protein degradation (Ciechan-
over 1998; Glover and Lindquist 1998). Meanwhile,
medical scientists have become acutely aware that pro-
tein aggregates and protein damage are significant fac-
tors in the pathogenesis of heritable diseases such as
cystic fibrosis and of acquired disorders such as ischemic
strokes and heart attacks (for a review, see Thomas et
al. 1995; Benjamin and McMillan 1998). In addition,
the degree of aggregate formation in a cell can often be
modified by the expression of specific chaperones, sug-
gesting a possible avenue to alter the phenotype of many
human pathological states. Because several chaperones
are also heat shock proteins (HSPs), the well-established
cytoprotective and regulatory properties of HSPs may
be exploited as therapeutic targets for similar disorders.
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Stress Proteins in Endogenous Cellular Defense
Mechanisms
HSPs are best known as cytoprotective agents, and
several families of these proteins are conserved in all
living cells, ranging from bacteria to human cells. Sudden
heat stress (∼5C above normal growth temperature) up-
regulates many classes of HSPs, a response often called
the “heat shock response.” Since diverse stresses (e.g.,
ischemia, heavy metals, amino acid analogues, and mu-
tant or abnormal proteins) also induce the expression
of HSP genes, the term “stress proteins” may be pre-
ferred. HSPs function as molecular chaperones, under
both stressed and normal conditions, to assist polypep-
tide chain folding and assembly into its secondary and
higher-order structures (Hartl 1996). In addition, HSP
chaperones assist in the repair of denatured proteins or
their degradation after heat shock.
The induction of HSP expression is crucial for the
survival of cells and, ultimately, organisms under
stressed conditions. Rapid induction is thus a central
conserved feature of the HSPs (Morimoto 1998). This
property helps explain the long-standing observation
that a brief, sublethal pretreatment of cells and organs
with heat stress elicits a powerful transient protection
against a subsequent severe heat shock (thermotoler-
ance) or different forms of stress (cross-tolerance).While
studies (discussed below) in ischemic brain and cardiac
protection have begun to establish direct causal rela-
tionships, the potential roles of stress proteins in pro-
tecting different cells and organs have now been ex-
tended to include a range of human pathologic condi-
tions.
Regulation and Function of the Heat Shock Response
How diverse physiological stimuli are sensed in the
cell and transmitted to evoke the heat shock response is
the focus of active investigation with potential clinical
significance. In vertebrates, stress-inducible up-regula-
tion of Hsp genes is controlled by the family of DNA-
binding proteins, or heat shock transcription factors
(HSFs) (Wu 1995). Under unstressed conditions, eukar-
yotic HSFs are maintained in the latent, non–DNA-bind-
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ing state by one or more negative regulators such as
Hsp90 or Hsp70 (Morimoto 1998). Physiological
stresses, such as heat and ischemia, result in the acti-
vation of HSF monomers to form homotrimers, trans-
locate into the nucleus, and bind, with high affinity, to
the conserved upstream heat shock elements (HSEs) con-
tained in the promoters of all heat shock genes (for a
review, see Wu 1995).
Prior exposure of cells to arachidonic acid, a potent
mediator of the inflammatory response, lowers the tem-
perature threshold for eliciting the heat shock response
in cultured cells (Jurivich et al. 1994). One potential
implication of these findings is that supraphysiologic
heat shock is not necessary for the heat shock response
in humans. In principle, multiple factors, such as cyto-
kines and prostaglandins, could induce this response at
temperatures present during febrile illness. Although re-
cent studies suggest heat shock and oxidative stress can
act directly on HSF activation in vitro, a growing body
of knowledge supports the current concept that mis-
folded or damaged proteins themselves are the proxi-
mate signals in the activating of gene expression in spe-
cific intracellular compartments and organelles.
Recent genetic studies have identified discrete sensing
that up-regulates molecular chaperones in various sub-
cellular compartments. Basal levels of protein folding
and misfolding are apparently regulated by the consti-
tutive pool of chaperone networks to maintain cellular
homeostasis. If this capacity is exceeded in the cytosol,
because of either environmental or metabolic changes,
the HSF1-mediated pathway is activated. However, an
independent regulatory pathway has evolved to respond
to excess levels of unfolded protein in the endoplasmic
reticulum—termed the “unfolded protein response”
(UPR). Activation of the UPR pathway requires the en-
doplasmic reticulum (ER)–resident transmembrane re-
ceptor, Ire1p, which senses the presence of unfolded pro-
teins and transduces this signal by stabilizing the
transcription factor, Hac1p (Cox et al. 1996). Hac1p
uses a novel mechanism of mRNA splicing, which is
extremely short-lived, to up-regulate the expression of
ER-Hsp70 homolog, Grp78, thus enabling tight control
of the unfolded response in this compartment (Sidrauski
et al. 1996). Recent evidence also suggests this mecha-
nism may be conserved in mammalian cells as well (Sid-
rauski et al. 1998).
Denatured and misfolded proteins that cannot be re-
folded by the molecular chaperones are efficiently tar-
geted for removal by intracellular proteolysis. The ubi-
quitin-proteasome machinery is used in the turnover of
some naturally short-lived cytoplasmic proteins that are
targeted for ubiquitin-proteasome–mediated protein
degradation. Ubiquitin, a 76–amino acid polypeptide, is
covalently linked to intracellular proteins, which are
subsequently degraded by the multisubunit 26S protea-
some (for a review, see Ciechanover 1998). Available
evidence suggests that the ubiquitin-proteasome ma-
chinery plays a pivotal role in disease pathogenesis
through effects for increased protein degradation of mu-
tant or misfolded proteins in many inherited and ac-
quired pathological states (Ciechanover 1998).
Protein aggregation is a hallmark of many human dis-
orders, such as Huntington disease, Alzheimer disease,
amyloidosis, cystic fibrosis, and hypertrophic cardio-
myopathy. Several classes of molecular chaperones have
been shown to mitigate protein aggregation, either by
preventing protein aggregation or by solubilizing exist-
ing aggregates (Glover and Lindquist 1998). Thus,
Hsp104, a yeast cytosolic molecular chaperone, appears
to be in the latter category and is required for recovery
of cell growth after heat shock.Many of the other classes
of chaperones, including the major Hsp70 and
small–molecular weight Hsps (heme oxygenase [Hsp32],
Hsp25/27, and aB-crystallin), facilitate protein folding
and prevent protein aggregation. In the endoplasmic re-
ticulum, similar functions are thought to be mediated
by the Ca2-binding glucose-regulated class of HSPs,
Grp170, Grp94, Grp78/BiP, Grp58, and Hsp47. Grp78/
BiP, one of the best characterized of the ER molecular
chaperones (immunoglobulin-binding protein), interacts
with many secretary and membrane proteins in the ER
during their maturation (for a review, see Gething and
Sambrook 1992).
Chaperones that prevent aggregate formation most
likely act by binding transiently to exposed hydrophobic
surfaces on partially folded proteins, thereby reducing
the concentration of free intermediates of protein fold-
ing. Recent studies of the common DF508 mutation of
the cystic fibrosis transmembrane conductance regulator
(CFTR) by Johnston and colleagues (1998) have shown
that multiubiquinated, mutant CFTR aggregates as a
pericentriolar structure, termed the “aggresome.” Ag-
gresome formation is accompanied by microtubule re-
distribution, which forms a cage around the aggresome.
Biochemical studies have shown that the cytosolic
Hsc70 chaperone increases the productive folding of the
common DF508 mutation of the CFTR and decreases
its aggregation (Strickland et al. 1997). Treating the cells
with lowered temperature or osmolytes, such as glycerol,
stabilizes protein folding by favoring the hydration of
molecules in the native state. Interestingly, the chemical
chaperones—glycerol, dimethylsulfoxide, and trimethy-
lamine N-oxide—have been shown to improve the fold-
ing and processing of DF508 CFTR significantly in cul-
tured cells. Studies of chemical chaperones provide a
rationale basis for potential therapeutic strategies for
correcting other protein-folding defects.
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Protein Oxidative Damage Occurs during Ischemic
Stroke and Myocardial Disease
Timely restoration of coronary blood flow after stroke
or infarction is required to salvage ischemic organs such
as the brain and heart. The amount of tissue damage
after a catastrophic event such as a heart attack or stroke
is the primary determinant of an individual’s morbidity
and survival. Although cell death does not occur im-
mediately after such stress, subsequent tissue deterio-
ration is due primarily to the limited capacity of post-
mitotic cells (e.g., cardiomyocytes and neurons) to
proliferate after lethal injury. Because thrombolytic ther-
apy is contraindicated in many patients with acute ische-
mic syndromes, treatments that speed the recovery of
injured cells may be the most promising strategy for
minimizing long-term damage in the heart and brain.
Protein unfolding and aggregation remain a hazard
even after blood flow is restored to ischemic tissue.
Highly reactive oxygen-free radicals may be generated
from the mitochondrial electron-transport system, a po-
tential source of protein damage during reperfusion. Re-
duced efficacy of antioxidant networks and the increased
production of reactive oxygen species could, in theory,
increase oxidative stress/damage, the main pathogenic
mechanism in oxidative protein damage and lipid per-
oxidation associated with age-related syndromes. Such
concepts have inspired the hope that molecular chap-
erones could mitigate specific deleterious events in the
aging process.
Stress Proteins Afford Protection in Intact Organs
A substantial amount of literature has described the
protective effect of HSPs, especially Hsp70, againstmyo-
cardial ischemia–reperfusion injury, (for a review, see
Benjamin and McMillan 1998). Early observations in-
dicated that increased expression of Hsp70, induced by
hyperthermal stress or sublethal ischemia, could reduce
infarct size and arrhythmias and improve postischemic
functional recovery. Forced expression of Hsp70 pro-
vided a cytoprotective effect in the in vitro cell culture
subjected to simulated ischemia. More recently, Suzuki
et al. (1997) reported that intracoronary infusion of the
human hsp70 gene carried by virus liposome improved
postischemic recovery (Suzuki et al. 1997). Studies in
transgenic mice show that stress protein–mediated cy-
toprotection after transient global or regional ischemia
extends even to the intact heart and brain (Marber et
al. 1995; Plumier et al. 1995, 1997; Radford et al. 1996).
In addition to Hsp70, the small HSPs aB-crystallin and
Hsp27, when overexpressed in isolated adult or neonatal
cardiomyocytes, protected against simulated ischemia
(Martin et al. 1997). The effect of aB-crystallin in this
assay is particularly striking in light of recent evidence
that the endogenous aB-crystallin gene (CRYAB) is re-
quired for normal cardiac function.
Missense Mutation of aB-crystallin Chaperone Causes
Cardiac and Skeletal Myopathy
Since the early 1980s, several reports have described
neuromuscular disorders with cardiac and skeletal mus-
cle involvement in which the muscle-specific interme-
diate protein desmin is overexpressed and deposited in
disordered form in cardiac and other muscle cells (Os-
born and Goebel 1983). This desmin-related myopathy
(DRM) is characterized by variable, but delayed, onset
of proximal and distal muscle weakness and all three
major forms of cardiomyopathy (i.e., dilated, hypertro-
phic, and restrictive). Patients with this condition typi-
cally exhibit first-degree atrioventricular (AV) block and
other AV conduction abnormalities, progressive deteri-
oration of ventricular function, congestive heart failure,
and death from either intractable pump failure or lethal
arrhythmias.
The histologic hallmarks of DRM in endomyocardial
or skeletal muscle biopsy samples are accumulations of
dense deposits and aggregate formation of intermediate
filaments (IFs). These comprise 8–10-nm filaments that
are intermediate between actin filaments (5–7 nm) and
myosin filaments (14 nm) (Fuchs and Weber 1994). Be-
sides desmin, other proteins found in the aggregates in-
clude the aB-crystallin chaperone and ubiquitin. Excess
amounts of IFs and associated proteins, desmin and aB-
crystallin chaperone, have been confirmed in the affected
tissues by western blot analysis. On the basis of ultra-
structural analysis, Goebel (1997) has recently proposed
two major classifications of desmin myopathy—namely,
granulomatous (type I) and cytoplasmic inclusion (type
II). Both familial and sporadic cases have been described
in the literature worldwide. The autosomal dominant
inheritance pattern is typically the granulomatous type,
which is not found in other forms of dilated cardiom-
yopathy (Goebel 1997).
A significant breakthrough into the etiology of desmin
myopathy came recently when a missense mutation was
mapped to the muscle-specific IF desmin in affected in-
dividuals (Goldfarb et al. 1998). Soon thereafter, Vicart
and colleagues (1998) excluded mutations of the desmin
gene in a French pedigree but found a missense mutation
of aB-crystallin (Arg120Gly), whichmapped to the locus
of DRM on chromosome 11q21–23 and cosegregated
with the disease phenotype. These are the first findings
to implicate an HSP with chaperone properties in a hu-
man cardiovascular disorder. Moreover, these aggregates
in aB-crystallinR120G myopathy, found in cardiac or skel-
etal biopsy samples, are strikingly reminiscent of the
Figure 1 A hypothetical model of mutant aB-crystallin chaperone in cardiomyopathy. Besides being expressed in the vertebrate lens, the
aB-crystallin chaperone is an abundant cytosolic protein of striated muscle, such as the heart and skeletal muscle. This chaperone shows a
tendency to transiently interact with components of the cytoskeleton, such as Z-discs, a major site of force generation, and IFs (e.g., vimentin
and desmin). A missense mutation in the aB-crystallin gene (CRYAB) is proposed to cause misfolding of mutant protein whose major fate in
the cell is determined by the ubiquitin-proteasome degradation. Potential factors for triggering aggregate formation may include the overpro-
duction of mutant protein, perhaps the result of the stress-response HSF1 regulatory pathway or alteration in the capacity of proteasome
degradation, or both. Besides ubiquitinated mutant proteins, a common pathogenic mechanism has been proposed because similar aggregates,
termed “aggresomes,” have been shown recently to contain IFs (Johnston et al. 1998). It is conceivable that the myopathic effects of aggresome
formation are causal factors in disease pathogenesis through effects that disorganize the cytoskeleton and impair contractile performance,
resulting in congestive heart failure and lethal arrhythmias.
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CFTR mutant aggresomes with the IF protein vimentin
(Johnston et al. 1998), suggesting a common pathogenic
mechanism in these inherited diseases.
Perspectives
Many lines of evidence now indicate that molecular
chaperones are key mediators of protein-folding path-
ways and that misfolded or abnormal proteins arising
from acquired disorders or genetic errors play primary
etiologic roles in the pathogenesis of cardiac diseases.
The effects of the aB-crystallinR120G mutation in cardio-
myopathy remain uncertain, but several models appear
to be readily testable. The hypothesis that this mutation
compromises aB-crystallin activity as a chaperone has
yet to be shown biochemically. This mutation is pre-
sumed to act as a dominant negative allele that interferes
with the integrity and function of the IF protein inmuscle
cells. Indeed, Bennardini et al. (1992) report that desmin
serves as a substrate of the aB-crystallin chaperone in
vitro. Conceivably, the aB-crystallin chaperonemay play
complementary roles along with hsp27 in cross-bridging
actin filaments in the Z-disc of the sarcomere. The ab-
sence of dynamic remodeling and the abnormal archi-
tecture of the actin cytoskeleton would be predicted to
interfere with force generation during muscle contrac-
tion. The physiological milieu inside the cell may also
be adversely affected by accumulating abnormal pep-
tides that escape from proteolysis and ubiquitin-protea-
some degradative pathways. It is conceivable that path-
ogenic mechanisms that promote aggregate formation
may also activate protective mechanisms, and, indeed,
it is well established that increased contractile activity
up-regulates aB-crystallin expression (Neufer et al.
1996). Onset of symptoms may then occur only when
such protective mechanisms prove inadequate, tipping
the balance toward cumulative myocyte loss, compen-
satory hypertrophy, and secondary left ventricular dil-
atation (fig. 1).
A major goal of future research is to determine
whether the tendency for aggregate formation is a critical
factor in the pathogenesis of human diseases. Small-an-
imal models of human genetic disorders provide a pow-
erful experimental approach to determine the effects of
physiological perturbations in the intact organism, such
as misfolded protein expression that mimics the condi-
tion of cardiomyopathy in humans. Results of such stud-
ies can help in establishing a cause-and-effect relation-
ship and in explicating potential mechanisms by the
alterations in the functions of a muscle-specific chap-
erone as related to a cardiomyopathy inmammals.Hsf1-
null mice, now under development (McMillan et al.
1998), will permit the testing of other crucial questions.
These animals should lack the endogenous heat shock
response, although it might be restored, under controlled
conditions, to test the physiological adaptation to mu-
tant protein expression. This system might be advan-
tageous in studying the effects of specific chaperone al-
leles, such as the aB-crystallinR120G, in an intact animal.
Such studies have major implications for cardiac diseases
with similar clinical features (Geisterfer-Lowrance et al.
1996); furthermore, unambiguous answers could chal-
lenge the belief that aggregate formation is a secondary,
and not a primary, cause of the pathogenesis of certain
human diseases.
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